scispace - formally typeset
A

Angelika Amon

Researcher at Massachusetts Institute of Technology

Publications -  201
Citations -  29098

Angelika Amon is an academic researcher from Massachusetts Institute of Technology. The author has contributed to research in topics: Aneuploidy & Mitotic exit. The author has an hindex of 78, co-authored 200 publications receiving 26171 citations. Previous affiliations of Angelika Amon include Cold Spring Harbor Laboratory & University of California, San Francisco.

Papers
More filters
Journal ArticleDOI

Aneuploid proliferation defects in yeast are not driven by copy number changes of a few dosage-sensitive genes

TL;DR: It is concluded that phenotypic thresholds can be crossed by mass action of copy number changes that, on their own, are benign.
Journal ArticleDOI

Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

Daniel J. Klionsky, +2522 more
- 01 Jan 2016 - 
TL;DR: Author(s): Klionsky, DJ; Abdelmohsen, K; Abe, A; Abedin, MJ; Abeliovich, H; A Frozena, AA; Adachi, H, Adeli, K, Adhihetty, PJ; Adler, SG; Agam, G; Agarwal, R; Aghi, MK; Agnello, M; Agostinis, P; Aguilar, PV; Aguirre-Ghis
Journal ArticleDOI

Phosphorylation-Mediated Clearance of Amyloid-like Assemblies in Meiosis.

TL;DR: It is shown that multi-site phosphorylation of Rim4 is critical for its regulated disassembly and degradation and that failure to clear Rim4 assemblies interferes with meiotic progression, and that the natural pathways by which cells process these structures could be deployed to act on disease-related amyloids.
Journal ArticleDOI

Why haploinsufficiency persists.

TL;DR: The origin of haploinsufficiency is investigated by creating a comprehensive dosage sensitivity data set for genes under their native promoters, and a dosage-stabilizing hypothesis is proposed to explain its persistence over evolutionary time.